Do you want to read an article? Please log in or register.
Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures
Epilepsy
Related content
Epilepsy
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
Epilepsia.
Krauss GL, Perucca E, Kwan P, Ben-Menachem E, Wang XF, Shih JJ, Patten A, Yang H, Williams B, Laurenza A
doi: 10.1111/epi.14044.
Epilepsy
Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures
Epilepsia.
Fogarasi A, Flamini R, Milh M, Phillips S, Yoshitomi S, Patten A, Takase T, Laurenza A, Ngo LY
doi: 10.1111/epi.16413.
Epilepsy
Pregabalin adjunctive therapy for focal onset seizures in children 1 month to <4 years of age: A double-blind, placebo-controlled, video-electroencephalographic trial
Epilepsia.
Mann D, Antinew J, Knapp L, Almas M, Liu J, Scavone J, Yang R, Modequillo M, Makedonska I, Ortiz M, Kyrychenko A, Nordli D, Farkas V, Farkas MK, A0081042 study group
doi: 10.1111/epi.16466.
RECOMMENDED
Epilepsy
Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
Steinhoff BJ, Patten A, Williams B, Malhotra M
doi: 10.1111/epi.16428.
Epilepsy
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
O'Brien TJ, Borghs S, He QJ, Schulz AL, Yates S, Biton V
doi: 10.1111/epi.16484.
Epilepsy
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study
Epilepsia.
Trinka E, Ben-Menachem E, Kowacs PA, Elger C, Keller B, Löffler K, Rocha JF, Soares-da-Silva P
doi: 10.1111/epi.13993.
Epilepsy
Safety and tolerability associated with chronic intermittent use of diazepam buccal film in adult, adolescent, and pediatric patients with epilepsy
Epilepsia.
Seinfeld S, Gelfand MA, Heller AH, Buan C, Slatko G
doi: 10.1111/epi.16696.
Epilepsy
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies
Epilepsia.
Rektor I, Krauss GL, Inoue Y, Kaneko S, Williams B, Patten A, Malhotra M, Laurenza A, Wechsler RT
doi: 10.1111/epi.16573.
RECOMMENDED
Epilepsy
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
Sperling MR, Klein P, Aboumatar S, Gelfand M, Halford JJ, Krauss GL, Rosenfeld WE, Vossler DG, Wechsler R, Borchert L, Kamin M
doi: 10.1111/epi.16525.